CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $139,000 | -32.5% | 42,976 | -12.6% | 0.00% | – |
| Q2 2021 | $206,000 | -51.9% | 49,174 | -42.9% | 0.00% | -100.0% |
| Q1 2021 | $428,000 | -72.2% | 86,064 | -29.3% | 0.00% | -66.7% |
| Q4 2020 | $1,538,000 | -6.8% | 121,806 | -27.6% | 0.00% | -25.0% |
| Q3 2020 | $1,650,000 | -3.1% | 168,140 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $1,702,000 | +30.0% | 171,463 | +15.8% | 0.00% | +33.3% |
| Q1 2020 | $1,309,000 | +77.9% | 148,053 | +85.3% | 0.00% | +200.0% |
| Q4 2019 | $736,000 | -0.8% | 79,881 | -36.7% | 0.00% | 0.0% |
| Q3 2019 | $742,000 | +282.5% | 126,103 | +679.6% | 0.00% | – |
| Q2 2019 | $194,000 | -83.7% | 16,175 | -82.9% | 0.00% | -100.0% |
| Q4 2018 | $1,187,000 | -32.1% | 94,650 | -19.4% | 0.00% | 0.0% |
| Q3 2018 | $1,749,000 | +33.0% | 117,499 | +51.0% | 0.00% | 0.0% |
| Q2 2018 | $1,315,000 | -65.1% | 77,807 | -52.8% | 0.00% | -50.0% |
| Q1 2018 | $3,773,000 | +396.4% | 164,718 | +460.7% | 0.01% | +500.0% |
| Q4 2017 | $760,000 | +72.7% | 29,378 | -31.2% | 0.00% | 0.0% |
| Q4 2016 | $440,000 | – | 42,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |